News from inovio pharmaceuticals inc

09:15 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced successful results from its randomized, double-blind, placebo-controlled phase II...

Jul 01, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced that it has been added to the Russell Global, Russell 2000 and Russell Microcap...

Jun 23, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity,...

Jun 17, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has expanded its existing license agreement with the University of Pennsylvania, adding exclusive...

Jun 16, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Present at Upcoming Healthcare Conferences

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President & CEO, Dr. J. Joseph Kim, will participate in a panel at the Piper...

Jun 11, 2014, 09:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Clarifies Facts of its VGX-3100 Phase II Trial and Immunotherapy Technology

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) wishes to clarify that a third party article published on June 10, 2014, was misrepresentative of...

Jun 10, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Initiates Immune Therapy Trial for Head & Neck Cancer Caused by HPV

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a...

May 30, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Announces Reverse Stock Split Date

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective...

May 27, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Breakthrough DNA-Based Monoclonal Antibody Therapy Completely Protects Animals From Lethal Viral Challenge

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya...

May 27, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Subsidiary Sells Animal Health Assets

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its 90%-owned subsidiary, VGX Animal Health, Inc. (VAH), has concluded an...

May 23, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Announces 1 For 4 Reverse Split

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's...

May 21, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. Joseph Kim, President and CEO, will give a corporate presentation at the...

May 13, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today it acquired worldwide rights (excluding China) for early preclinical therapies...

May 12, 2014, 06:10 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Reports 2014 First Quarter Financial Results

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended March 31,...

May 05, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its first quarter...

Apr 01, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible...

Mar 26, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was recognized with three industry awards at the World Vaccine Congress,...

Mar 17, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013. Total...

Mar 12, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its fourth quarter...

Mar 04, 2014, 09:49 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today closed its previously announced underwritten public offering of...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge